CGEN COMPUGEN LTD

Nasdaq cgen.com


$ 1.87 $ -0.07 (-3.85 %)    

Friday, 17-Oct-2025 17:10:05 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.875
$ 2.00
$ 1.74 x 205
$ 2.03 x 201
$ 1.81 - $ 2.00
$ 1.13 - $ 2.66
678,881
na
167.89M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 compugen-publishes-pooled-data-showing-com701-activity-in-platinum-resistant-ovarian-cancer-ahead-of-esmo-presentation

 Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computation...

 compugen-q2-eps-008-misses-007-estimate-sales-1257m-miss-3952m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.07) by...

 compugen-q1-eps-008-misses-006-estimate-sales-228m-miss-370m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by...

 compugen-q4-2024-gaap-eps-007-may-not-be-comparable-to-007-estimate-sales-147m-may-not-be-comparable-to-1743m-estimate

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $0.07 by 2...

 compugen-expands-its-intellectual-property-portfolio-with-new-us-patent-covering-triple-combination-use-of-com902-reduced-fc-anti-tigit-with-anti-pd-1-and-anti-pvrig-antibodies

The company announced that the United States Patent and Trademark Office (USPTO) has granted the Company a new patent covering ...

 compugen-q3-2024-gaap-eps-001-misses-006-estimate-sales-17132m-miss-17862m-estimate

Compugen (NASDAQ:CGEN) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.06 by 8...

 compugen-q2-eps-002-beats-007-estimate-sales-670m

Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 7...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION